# Behavidence

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/behavidence

- Industry: Healthcare Specialists
- Headquarters: New York, US
- Website: www.behavidence.com
- Total disclosed funding: $4.3M
- Latest round: Seed (Mar 10, 2022)
- Investors on record: 3

## About

Based in New York, US, and founded in 2020 by its CEO Roy Cohen, and CTO Dr. Girish Srinivasan, Behavidence, Inc. operates as digital phenotyping for mental health that can assess through personal device interactions. In March 2022, Behavidence, Inc. raised USD 4.3 million in seed funding led by returning investor Welltech Ventures, with participation from other returning investors Arc Impact and Longevity Venture Partners.

Behavidence, Inc. develops machine learning-based tools to detect and assist with remote monitoring and management of mental health conditions such as depression, anxiety, ADHD, and more through passive digital biomarkers. The company’s products can be used as a measurement-based outcome to monitor employee burnout, and stress, predict relapse of conditions, screening, and remote monitoring for clinical interventions and comorbid conditions. The company's application Behavidence is available for Android devices. Its clients include the Department of Veterans Affairs, Discovery Health Insurance, and Essen Health Care.

The company will use the seed funding to develop its machine learning-based tools.

## Funding rounds

- Seed, Mar 10, 2022, $4.3M — Longevity Venture Partners, Arc Impact, Welltech Ventures

## Investors

- Longevity Venture Partners (https://capitalatlas.ai/funds/longevity-venture-partners) — Seed
- Arc Impact (https://capitalatlas.ai/funds/arc-impact) — Seed
- Welltech Ventures (https://capitalatlas.ai/funds/welltech-ventures) — Seed